Kornitzer Capital Management Inc /Ks / ABT
Kornitzer Capital Management Inc /Ks’s Abbott Laboratories Position
Does Kornitzer Capital Management Inc /Ks own Abbott Laboratories (ABT)? Yes — 369.8K shares worth $38M (+0.82% of its 13F portfolio) as of Q1 2026, down from 377.3K shares the prior filed quarter.
Position Value
$38M
Q1 2026
Shares
369.8K
% of Portfolio
+0.82%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 369.8K | $38M | +0.82% |
| Q4 2025 | 377.3K | $47M | +0.98% |
| Q3 2025 | 383.2K | $51M | +1.03% |
| Q2 2025 | 386.0K | $53M | +1.06% |
| Q1 2025 | 388.5K | $52M | +1.06% |
| Q4 2024 | 392.6K | $44M | +0.87% |
| Q3 2024 | 383.3K | $44M | +0.81% |
| Q2 2024 | 379.0K | $39M | +0.75% |
| Q1 2024 | 375.6K | $43M | +0.78% |
| Q4 2023 | 347.4K | $38M | +0.74% |
| Q3 2023 | 396.9K | $38M | +0.79% |
| Q2 2023 | 300.8K | $33M | +0.64% |
| Q1 2023 | 301.9K | $31M | +0.61% |
| Q4 2022 | 303.6K | $33M | +0.67% |
| Q3 2022 | 305.8K | $30M | +0.63% |
| Q2 2022 | 315.8K | $34M | +0.69% |
| Q1 2022 | 307.7K | $36M | +0.60% |
| Q4 2021 | 338.7K | $48M | +0.71% |
| Q3 2021 | 349.7K | $41M | +0.63% |
| Q2 2021 | 349.9K | $41M | +0.61% |
| Q1 2021 | 356.1K | $43M | +0.68% |
| Q4 2020 | 367.5K | $40M | +0.68% |
| Q3 2020 | 373.8K | $41M | +0.80% |
| Q2 2020 | 414.0K | $38M | +0.76% |
| Q1 2020 | 451.7K | $36M | +0.85% |
| Q4 2019 | 461.1K | $40M | +0.71% |
| Q3 2019 | 493.1K | $41M | +0.75% |
| Q2 2019 | 515.6K | $43M | +0.76% |
| Q1 2019 | 524.7K | $42M | +0.75% |
| Q4 2018 | 529.6K | $38M | +0.77% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kornitzer Capital Management Inc /Ks’s full portfolio or all institutional holders of ABT.